Cargando…

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis

BACKGROUND: Resting cerebral blood flow (rCBF) in striatum and thalamus is increased in medicated patients with psychosis, but whether this is caused by treatment or illness pathology is unclear. Specifically, effects of partial dopamine agonism, sex, and clinical correlates on rCBF are sparsely inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bojesen, Kirsten Borup, Glenthøj, Birte Yding, Sigvard, Anne Korning, Tangmose, Karen, Raghava, Jayachandra Mitta, Ebdrup, Bjørn Hylsebeck, Rostrup, Egill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600821/ https://www.ncbi.nlm.nih.gov/pubmed/36754993 http://dx.doi.org/10.1017/S0033291723000144

Ejemplares similares

M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model
por: Sigvard, Anne K., et al.
Publicado: (2022)

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST
por: Tangmose, Karen, et al.
Publicado: (2018)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten B., et al.
Publicado: (2020)

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2021)

F16. GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS
por: Bojesen, Kirsten, et al.
Publicado: (2018)

O9.5. NORMALIZATION OF DISTURBANCES IN PREDICTION ERROR IS RELATED TO TREATMENT RESPONSE AND RELATED TO THALAMIC GLUTAMATE LEVELS IN NON-RESPONDERS
por: Tangmose, Karen, et al.
Publicado: (2020)

O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients
por: Ebdrup, Bjørn H., et al.
Publicado: (2019)

M148. NORMALIZATION IN REWARD PROCESSING DURING INITIAL TREATMENT MAY PREDICT LONG-TERM CLINICAL OUTCOME IN ANTIPSYCHOTIC NAïVE SCHIZOPHRENIA PATIENTS
por: Nielsen, Mette, et al.
Publicado: (2020)

Striatal Volume Increase After Six Weeks of Selective Dopamine D(2/3) Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
por: Andersen, Helle G., et al.
Publicado: (2020)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST
por: Jessen, Kasper, et al.
Publicado: (2018)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers
por: Bojesen, Kirsten Borup, et al.
Publicado: (2018)

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
por: Ebdrup, Bjørn H, et al.
Publicado: (2012)

Supplementary data for a focused review and meta-analysis of (1)H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states
por: Wenneberg, Christina, et al.
Publicado: (2019)

A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data
por: Ambrosen, Karen S., et al.
Publicado: (2020)

S12. A MACHINE LEARNING FRAMEWORK FOR ROBUST AND RELIABLE PREDICTION OF SHORT- AND LONG-TERM CLINICAL RESPONSE IN INITIALLY ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BASED ON MULTIMODAL NEUROPSYCHIATRIC DATA
por: Ambrosen, Karen S, et al.
Publicado: (2020)

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients
por: Düring, Signe, et al.
Publicado: (2015)

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis
por: Myken, Anders N, et al.
Publicado: (2022)

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL
por: Kristensen, Tina, et al.
Publicado: (2020)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Frontal D(2/3) Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology
por: Nørbak-Emig, Henrik, et al.
Publicado: (2016)

Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome
por: Wulff, Sanne, et al.
Publicado: (2015)

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
por: Ishøy, Pelle L, et al.
Publicado: (2014)

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
por: Dahl, Anne Sofie A., et al.
Publicado: (2023)

Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics
por: Nejad, Ayna B, et al.
Publicado: (2012)

Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
por: Kristensen, Tina D., et al.
Publicado: (2019)

The impact of schizophrenia and intelligence on the relationship between age and brain volume
por: Jensen, Maria H., et al.
Publicado: (2018)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

O3.3. REWARD PROCESSING AS A VULNERABILITY INDICATOR FOR PSYCHOSIS: RESULTS FROM A TWIN STUDY
por: Nielsen, Mette, et al.
Publicado: (2018)

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
por: Kristensen, Tina D., et al.
Publicado: (2020)

T16. GLUTAMATERGIC CHANGES IN UHR
por: Wenneberg, Christina, et al.
Publicado: (2018)

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
por: Rasmussen, Jesper Ø., et al.
Publicado: (2022)

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia
por: Bak, Nikolaj, et al.
Publicado: (2013)

Effects of prenatal nutrient supplementation and early life exposures on neurodevelopment at age 10: a randomised controlled trial - the COPSYCH study protocol
por: Mohammadzadeh, Parisa, et al.
Publicado: (2022)

Volumetric Changes in the Basal Ganglia After Antipsychotic Monotherapy: A Systematic Review
por: Ebdrup, B.H, et al.
Publicado: (2013)

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
por: Bak, N, et al.
Publicado: (2017)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_um2nqpq7pp4aipgq8invln7rjh